0 Комментарии
0 Поделились
655 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Charles Bonnet Syndrome Market – Vision Disorder Treatment, Neurology Insights & ForecastThe Charles Bonnet Syndrome Market, characterized by the provision of diagnostic and therapeutic solutions for visually-impaired individuals experiencing complex visual hallucinations, is poised for significant expansion. This growth is fundamentally driven by the rising global prevalence of age-related macular degeneration (AMD), glaucoma, and other sight-loss conditions, particularly...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Europe Neurology Clinical Trials Market Growth Insights 2025-2034The Europe Neurology Clinical Trials Market is witnessing steady growth as the prevalence of neurological disorders such as Alzheimer’s, Parkinson’s, multiple sclerosis, and epilepsy continues to rise. Valued at USD 1.90 billion in 2024, the market is projected to reach USD 3.55 billion by 2034, registering a CAGR of 6.5% during the forecast period....0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How EHR Integration Enhances Efficiency in Neurology PracticesNeurology practices face unique challenges every single day. Managing complex patient histories, coordinating specialized treatments, and handling intricate billing processes demand precision. Electronic Health Record integration has become a game-changer for neurologists. It streamlines operations while improving patient care quality significantly. Let's explore how this technology transforms...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Market Segmentation – Oncology Dominates, Cardiology and Neurology SurgeWithin the Radiopharmaceutical Theranostics Market , the market is segmented by application, radioisotope, and end-user, revealing a dynamic landscape with distinct growth drivers. According to the MRFR report, by application, oncology is the largest segment, holding a significant share due to the increasing incidence of cancer globally. This segment is driven by the...0 Комментарии 0 Поделились 176 Просмотры 0 предпросмотр
-
Neurology Small Molecule API Market Graph: Growth, Share, Value, Size, and Insights"Executive Summary Neurology Small Molecule API Market: Growth Trends and Share Breakdown The global neurology small molecule API market size was valued at USD 19.77 billion in 2024 and is projected to reach USD 32.72 billion by 2032, with a CAGR of 6.50% during the forecast period of 2025 to 2032. Neurology Small Molecule API Market research report is a verified source of data and...0 Комментарии 0 Поделились 544 Просмотры 0 предпросмотр
-
Are Innovations in Treatment Improving Life for Parkinson’s Patients?Market Trends Shaping Executive Summary Parkinson’s Disease Treatment Market Size and Share CAGR Value Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period. A complete discussion...0 Комментарии 0 Поделились 625 Просмотры 0 предпросмотр
-
Are Neurovascular Stents Redefining Stroke Treatment Outcomes?Global Executive Summary Neurovascular Stents Market: Size, Share, and Forecast CAGR Value The global neurovascular stents market size was valued at USD 1.52 billion in 2025 and is expected to reach USD 3.25 billion by 2033, at a CAGR of 10.00% during the forecast period The complete Neurovascular Stents Market report is spread across a number of...0 Комментарии 0 Поделились 124 Просмотры 0 предпросмотр
-
Can Deep Brain Stimulation Systems Revolutionize Neurological Treatments in Europe?Executive Summary Europe Deep Brain Stimulation Systems Market: Share, Size & Strategic Insights CAGR Value Data Bridge Market Research analyses that the deep brain stimulation systems market value is USD 0.88 billion in 2022, is expected to reach USD 5.18 billion by 2030, at a CAGR of 24.8% during the forecast period 2023 to 2030. Europe Deep Brain Stimulation Systems Market...0 Комментарии 0 Поделились 145 Просмотры 0 предпросмотр
-
Multiple Sclerosis Market Will Emerging Therapies Transform Patient Outcomes?Executive Summary Multiple Sclerosis Market Size and Share Across Top Segments CAGR Value The global multiple sclerosis market was valued at USD 28.28 billion in 2024 and is expected to reach USD 37.96 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 3.75%, primarily driven by the anticipated launch of new therapies and advancements...0 Комментарии 0 Поделились 941 Просмотры 0 предпросмотр
-
Oxcarb 300 Tablet Uses for Brain Signal Control | Oxcarbazepine 300 mg Guide (US)Oxcarb 300, also known as Oxcarbazepine 300 mg, is a widely prescribed medication used to control abnormal brain signals, especially in people living with seizure disorders such as epilepsy. This guide is mainly targeted at readers in the United States, where Oxcarb 300 remains an important part of modern neurological treatment plans. Understanding how this medicine works, why doctors prescribe...0 Комментарии 0 Поделились 808 Просмотры 0 предпросмотр
-
What Innovations Are Shaping the Future of Parkinson’s Disease Treatment?Market Trends Shaping Executive Summary Parkinson’s Disease Treatment Market Size and Share CAGR Value Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period. This Parkinson’s...0 Комментарии 0 Поделились 456 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek